[Form 4/A] Vita Coco Company, Inc. Amended Insider Trading Activity

Rhea-AI Filing Summary

Martin Roper, a director and CEO of Vita Coco Company, Inc. (COCO), amended a Form 4 to report multiple sales of common stock executed pursuant to a Rule 10b5-1 trading plan on September 15–17, 2025. The Form 4/A shows a series of disposals reported as sales (code S) that reduced both direct and indirect beneficial holdings and reports weighted-average prices for the transactions in ranges approximately between $40.00 and $40.54 per share. The filing also discloses several fully vested and unvested non‑qualified stock options exercisable for large blocks of common stock, with exercise prices from $10.178 to $32.78 and various vesting schedules and expiration dates through 2035. The amendment restates the original Form 4 filed September 18, 2025.

Positive

• Sales were executed under a Rule 10b5-1 trading plan, indicating pre-established, documented trading instructions
• Amended Form 4 restates and clarifies prior reporting, improving transparency
• Indirect holdings are identified by named family trusts, providing clearer beneficial ownership structure

Negative

• Insider reported multiple share disposals on September 15–17, 2025, which reduced direct and indirect holdings
• Large outstanding option positions disclosed (aggregate underlying shares across grants), representing potential future share supply

Insights

Corporate Governance Expert

TL;DR Insider sales were executed under a pre-existing 10b5-1 plan; amendment improves disclosure clarity.

The filing shows that the reporting person used a Rule 10b5-1 trading plan to effect multiple stock sales on September 15–17, 2025, and subsequently amended the original Form 4 to restate those disclosures. From a governance perspective, use of a documented 10b5-1 plan is a compliance best practice because it reduces the appearance of opportunistic timing by insiders. The amendment filing further enhances transparency by clarifying weighted-average price ranges and by identifying shares held indirectly through identified family trusts. Material option holdings and their exercise prices and vesting schedules are fully disclosed, allowing stakeholders to assess potential future selling pressure as options vest.

Securities Analyst

TL;DR Reported sales and large outstanding options may increase share supply; trades were pre‑planned under 10b5-1.

The Form 4/A documents multiple disposals of common stock (reported as sales) across September 15–17, 2025, at weighted-average prices reported within ranges near $40 per share. The filing lists substantial holdings via non‑qualified stock options with exercise prices as low as $10.178 and as high as $32.78, and aggregate underlying share counts are disclosed per option grant. These details are useful for modeling potential dilution or future insider-driven supply if options are exercised and shares sold. The amendment clarifies earlier reporting and provides buyers and modelers with concrete price ranges and ownership changes to incorporate into short-term liquidity assessments.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Roper Martin

(Last) (First) (Middle)

250 PARK AVE SOUTH

SEVENTH FLOOR

(Street)

NEW YORK NY 10003

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)
09/18/2025

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/15/2025		S(1)		5,000	D	$40.088(2)	347,062	D
Common Stock	09/16/2025		S(1)		2,765	D	$40.008(3)	344,297	D
Common Stock	09/17/2025		S(1)		5,000	D	$40.217(4)	339,297	D
Common Stock	09/15/2025		S(1)		5,000	D	$40.091(5)	281,131	I	by Chris Roper FT(14)
Common Stock	09/16/2025		S(1)		2,325	D	$40.004(6)	278,806	I	by Chris Roper FT(14)
Common Stock	09/17/2025		S(1)		5,000	D	$40.233(7)	273,806	I	by Chris Roper FT(14)
Common Stock	09/15/2025		S(1)		5,000	D	$40.089(8)	281,131	I	by Peter Roper FT(15)
Common Stock	09/16/2025		S(1)		3,216	D	$40.006(9)	277,915	I	by Peter Roper FT(15)
Common Stock	09/17/2025		S(1)		5,000	D	$40.217(10)	272,915	I	by Peter Roper FT(15)
Common Stock	09/15/2025		S(1)		5,000	D	$40.083(11)	281,131	I	by Thomas Roper FT(16)
Common Stock	09/16/2025		S(1)		2,200	D	$40.006(12)	278,931	I	by Thomas Roper FT(16)
Common Stock	09/17/2025		S(1)		5,000	D	$40.225(13)	273,931	I	by Thomas Roper FT(16)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$10.178							(17)	09/19/2029	Common Stock	579,670		579,670	D
Non-Qualified Stock Option (right to buy)	$10.178							(18)	01/11/2031	Common Stock	40,950		40,950	D
Non-Qualified Stock Option (right to buy)	$15							(19)	10/21/2031	Common Stock	298,507		298,507	D
Non-Qualified Stock Option (right to buy)	$16.91							(20)	03/10/2033	Common Stock	46,875		46,875	D
Non-Qualified Stock Option (right to buy)	$26.18							(21)	03/04/2034	Common Stock	62,743		62,743	D
Non-Qualified Stock Option (right to buy)	$32.78							(22)	03/03/2035	Common Stock	70,715		70,715	D

Explanation of Responses:

1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.32, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.05, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.51, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.33, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.02, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.54, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

8. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.32, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

9. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.05, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

10. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.51, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

11. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.29, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

12. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.05, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

13. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.54, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

14. These shares are held by the Christopher G. Roper Exempt Family Trust.

15. These shares are held by the Peter S. Roper Exempt Family Trust.

16. These shares are held by the Thomas L. Roper Exempt Family Trust.

17. The stock option is fully vested and currently exercisable.

18. The stock option is fully vested and currently exercisable.

19. The stock option vests in four equal annual installments beginning on November 27, 2022.

20. The stock option vests in four equal annual installments beginning on March 10, 2024.

21. The stock option vests in four equal annual installments beginning on March 4, 2025.

22. The stock option vests in four equal annual installments beginning on March 3, 2026.

Remarks:

This Form 4/A amends and restates in its entirety the Form 4 filed by the reporting person on September 18, 2025.

	By: Alison Klein, Attorney-in-Fact For: Martin Roper	09/23/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Martin Roper report on Form 4/A for COCO?

The filing reports multiple sales of common stock executed September 15–17, 2025 under a Rule 10b5-1 plan, and discloses existing stock option grants.

Were the insider sales pre-planned or opportunistic?

The filing states the sales were effected pursuant to a Rule 10b5-1 trading plan, indicating they were pre-planned.

What price range is reported for the sales?

Weighted-average prices are reported with ranges approximately between $40.00 and $40.54 per share for the transactions disclosed.

How many option shares are disclosed and what are exercise prices?

Multiple non-qualified stock options are disclosed with underlying share amounts and exercise prices ranging from $10.178 to $32.78, exercisable and expiring on various dates through 2035.

Does the filing identify indirect ownership?

Yes. Shares held indirectly are identified as held by the Christopher G. Roper Exempt Family Trust, Peter S. Roper Exempt Family Trust, and Thomas L. Roper Exempt Family Trust.